176 related articles for article (PubMed ID: 14502009)
1. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
Churchyard GJ; Fielding K; Charalambous S; Day JH; Corbett EL; Hayes RJ; Chaisson RE; De Cock KM; Samb B; Grant AD
AIDS; 2003 Sep; 17(14):2063-70. PubMed ID: 14502009
[TBL] [Abstract][Full Text] [Related]
2. The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
Hermans SM; Grant AD; Chihota V; Lewis JJ; Vynnycky E; Churchyard GJ; Fielding KL
BMC Med; 2016 Mar; 14():45. PubMed ID: 27004413
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
van Halsema CL; Fielding KL; Chihota VN; Russell EC; Lewis JJ; Churchyard GJ; Grant AD
AIDS; 2010 Apr; 24(7):1051-5. PubMed ID: 20299958
[TBL] [Abstract][Full Text] [Related]
4. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
5. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
6. Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa.
Fielding KL; Grant AD; Hayes RJ; Chaisson RE; Corbett EL; Churchyard GJ
Contemp Clin Trials; 2011 May; 32(3):382-92. PubMed ID: 21193066
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
8. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
[TBL] [Abstract][Full Text] [Related]
10. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
Grant AD; Charalambous S; Fielding KL; Day JH; Corbett EL; Chaisson RE; De Cock KM; Hayes RJ; Churchyard GJ
JAMA; 2005 Jun; 293(22):2719-25. PubMed ID: 15941800
[TBL] [Abstract][Full Text] [Related]
11. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
12. Variation in incidences of tuberculosis in subgroups of South African gold miners.
Kleinschmidt I; Churchyard G
Occup Environ Med; 1997 Sep; 54(9):636-41. PubMed ID: 9423575
[TBL] [Abstract][Full Text] [Related]
13. A trial of mass isoniazid preventive therapy for tuberculosis control.
Churchyard GJ; Fielding KL; Lewis JJ; Coetzee L; Corbett EL; Godfrey-Faussett P; Hayes RJ; Chaisson RE; Grant AD;
N Engl J Med; 2014 Jan; 370(4):301-10. PubMed ID: 24450889
[TBL] [Abstract][Full Text] [Related]
14. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.
Charalambous S; Grant AD; Innes C; Hoffmann CJ; Dowdeswell R; Pienaar J; Fielding KL; Churchyard GJ
AIDS; 2010 Nov; 24 Suppl 5(0 5):S5-13. PubMed ID: 21079429
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
[TBL] [Abstract][Full Text] [Related]
16. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
17. Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.
Kendall EA; Azman AS; Maartens G; Boulle A; Wilkinson RJ; Dowdy DW; Rangaka MX
AIDS; 2019 Mar; 33(3):525-536. PubMed ID: 30325773
[TBL] [Abstract][Full Text] [Related]
18. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
[TBL] [Abstract][Full Text] [Related]
19. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.
Day JH; Charalambous S; Fielding KL; Hayes RJ; Churchyard GJ; Grant AD
Int J Tuberc Lung Dis; 2006 May; 10(5):523-9. PubMed ID: 16704034
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
Pho MT; Swaminathan S; Kumarasamy N; Losina E; Ponnuraja C; Uhler LM; Scott CA; Mayer KH; Freedberg KA; Walensky RP
PLoS One; 2012; 7(4):e36001. PubMed ID: 22558301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
